
New paper in @Technovation_J with @Ao_JingNing - We analysed shareholder letters from 24 pharma firms examining how their linguistic emphasis on open innovation partnerships aligns with active project counts across drug R&D phases. Check out the paper👇 sciencedirect.com/science/ar…














